During the last decade, noroviruses have gained media attention as the cause of large scale outbreaks of gastroenteritis on cruise ships, dormitories, nursing homes, etc. Although noroviruses do not multiply in food or water, they can cause large outbreaks because approximately 10 -100 virions are sufficient to cause illness in a healthy adult. Recently, it was shown that the activity of acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1) enzyme may be important in norovirus infection. In search of anti-noroviral agents based on the inhibition of ACAT1, we synthesized and evaluated the inhibitory activities of a class of pyranobenzopyrone molecules containing amino, pyridine, substituted quinolines, or 7,8-benzoquinoline nucleus. Key words: acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1), caliciviruses, norovirus, anti-noroviruses, pyranobenzopyrones.
The synthesis of pyranobenzopyrones 1 -7 stems from a reductive amination reaction 11 of amine 10 and various aldehydes, 11 -17 as depicted in Scheme 1. Initially, amine 10 was prepared via a four-step sequence of reactions starting from pyranobenzopyrones 9 by hydroboration-hydroxylation reaction followed by mesylation, displacement with sodium azide, and reduction with H 2 /Pd. 10 The synthesis was simplified by a one-pot hydroboration-amination reaction of 9 with BH 3 •THF followed by hydroxylamine-O-sulfonic acid 12 in 50% yield (Scheme 1). A mixture of two diastereomers in a ratio of 1:1 resulted at the newly created carbon center C12 from the hydroboration reaction indicated by its 1 H and 13 C NMR spectra. 
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3C (56% yield) 7 (62% yield) 12 Amide 8 was synthesized from the coupling reaction of quinoline-4-carboxylic acid (18), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and amine 10 in 65% yield (Scheme 2).
Aldehydes 11, 12, and 13A and carboxylic acid 18 along with various methylquinolines were obtained from commercial sources. Aldehydes 14A, 15, and 16 were prepared by benzylic oxidation with selenium dioxide 13 or bromination followed by hydrolysis/oxidation 14 of methylquinolines, and aldehydes 13B, 13C, 14B -14F, and 17 were achieved from free-radical heteroaromatic trioxanylation 15, 16 with trioxane-t-BuOOH-ferrous sulfate (Schemes 2 -4).
Hence, oxidation of 4-methylquinoline (19) with SeO 2 under refluxing toluene gave quinoline-4-carboxaldehyde (14A) in 73% yield along with a small amount of over oxidized carboxylic acid
(Scheme 2).
Similarly, quinoline-6-carboxaldehyde (15) was obtained from 6-methylquinoline (20) in 54% yield after the treatment with SeO 2 in refluxing xylene. To our surprise, oxidation of 8-methylquinoline (21) under similar reaction conditions provided only a trace amount of 8-quinoline-carboxaldehyde (16) . Apparently, methyl group appended on ring A of quinoline is activated toward oxidation, but methyl group on ring B is not, and a sluggish oxidation resulted. To overcome the problem, benzylic bromination of 21 was carried out.
Treatment of 21 with N-bromosuccinimide (NBS) and a catalytic amount of azobisisobutyronitrile (AIBN) followed by aqueous hydrolysis accompanying air oxidation gave aldehyde 16 (37% yield) 14 along with the hydrolyzed product, 6-hydroxymethylquinoline (22) (53% yield 
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Supplementary data
Synthetic procedure, analytical data, and protocols for antiviral evaluation are included.
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II.3. (5aS,7S)-3-Methyl-7-(1-(pyridin-4-ylmethylamino)propan-2-yl)-1H,7H-5a
II.5. (5aS,7S)-3-Methyl-7-(1-(quinolin-4-ylmethylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (4A
II.11. (5aS,7S)-7-(1-((2-(1,3,5-Trioxan-2-yl)quinolin-4-yl)methylamino)propan-2-yl)-3-methyl-6,7,8,9-tetrahydropyrano[4,3-b]chromen-1(5aH)-one (4E
II.12. (5aS,7S)-3-Methyl-7-(1-((4-methylquinolin-2-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (3B
II.13. (5aS,7S)-3-Methyl-7-(1-((6-methylquinolin-4-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (4F
II.14. (5aS,7S)-3-Methyl-7-(1-((6-methylquinolin-2-yl)methylamino)propan-2-yl)-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran (3C
II.16. N-(2-((5aS
,
II.28. Quinoline-8-carboxaldehyde (16)
.)
